• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Case report of thrombotic microangiopathy associated with subcutaneous interferon beta-1a: an emerging complication?

作者信息

Azkune Calle I, Sánchez Menoyo J L, Ruiz Ojeda J, García Moncó J C, Etxeguren Urkixo I

机构信息

Servicio de Neurología, Hospital de Galdakao-Usansolo, Galdakao, Bizkaia, España.

Servicio de Neurología, Hospital de Galdakao-Usansolo, Galdakao, Bizkaia, España.

出版信息

Neurologia. 2016 Sep;31(7):508-9. doi: 10.1016/j.nrl.2014.09.008. Epub 2014 Nov 11.

DOI:10.1016/j.nrl.2014.09.008
PMID:25449964
Abstract
摘要

相似文献

1
Case report of thrombotic microangiopathy associated with subcutaneous interferon beta-1a: an emerging complication?皮下注射干扰素β-1a相关血栓性微血管病的病例报告：一种新出现的并发症？
Neurologia. 2016 Sep;31(7):508-9. doi: 10.1016/j.nrl.2014.09.008. Epub 2014 Nov 11.
2
The Case | The young philosopher with multiple sclerosis and proteinuria.病例 | 患有多发性硬化症和蛋白尿的年轻哲学家
Kidney Int. 2016 Apr;89(4):961-3. doi: 10.1016/j.kint.2015.10.013.
3
Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a.皮下注射干扰素β-1a治疗血栓性微血管病、血栓性血小板减少性紫癜和溶血尿毒综合征的累积综述报告
Adv Ther. 2015 May;32(5):445-54. doi: 10.1007/s12325-015-0212-6. Epub 2015 May 20.
4
Long-term efficacy and safety of intramuscular interferon beta-1a: Randomized postmarketing trial of two dosing regimens in Japanese patients with relapsing-remitting multiple sclerosis.肌内注射干扰素β-1a 的长期疗效和安全性：两种剂量方案在日本复发缓解型多发性硬化症患者中的随机上市后试验。
Mult Scler Relat Disord. 2016 May;7:102-8. doi: 10.1016/j.msard.2016.02.002. Epub 2016 Feb 2.
5
Favorable outcome of interferon-beta associated thrombotic microangiopathy following treatment with corticosteroids, plasma exchange and rituximab: A case report.干扰素-β相关性血栓性微血管病经皮质类固醇、血浆置换和利妥昔单抗治疗后结局良好：一例报告。
Mult Scler Relat Disord. 2016 Nov;10:63-65. doi: 10.1016/j.msard.2016.09.002. Epub 2016 Sep 6.
6
Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis.干扰素β-1a治疗多发性硬化症所致的肾血栓性微血管病。
Drug Des Devel Ther. 2013 Aug 7;7:723-8. doi: 10.2147/DDDT.S42138. eCollection 2013.
7
Relationship between Interferon Beta-1A Administration and Intracranial Vascular Tone Regulation in Patients with Relapsing-Remitting Multiple Sclerosis: A Pilot Study.干扰素 β-1A 给药与复发缓解型多发性硬化患者颅内血管张力调节的关系：一项初步研究。
Biomed Res Int. 2017;2017:5421416. doi: 10.1155/2017/5421416. Epub 2017 Sep 13.
8
Thrombotic Microangiopathy Presenting with Intestinal Involvement Following Long-term Interferon-β1b Treatment for Multiple Sclerosis.长期使用β-1b干扰素治疗多发性硬化症后出现肠道受累的血栓性微血管病
Intern Med. 2018 Mar 1;57(5):741-744. doi: 10.2169/internalmedicine.9326-17. Epub 2017 Nov 20.
9
Necrotizing Fasciitis in a Patient on Long-Term Intramuscular Interferon-Beta for Multiple Sclerosis: A Case Report.患者长期接受肌肉内注射干扰素-β治疗多发性硬化后发生坏死性筋膜炎：病例报告。
JBJS Case Connect. 2020 Jan-Mar;10(1):e0288. doi: 10.2106/JBJS.CC.19.00288.
10
Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study.干扰素β-1a（安万特）作为未经治疗的多发性硬化症患者的一种治疗选择（AXIOM）：一项前瞻性观察研究。
Int J Mol Sci. 2015 Jul 6;16(7):15271-86. doi: 10.3390/ijms160715271.

引用本文的文献

1
Thrombotic Microangiopathy as a Life-Threatening Complication of Long-Term Interferon Beta Therapy for Multiple Sclerosis: Clinical Phenotype and Response to Treatment-A Literature Review.血栓性微血管病作为多发性硬化症长期β-干扰素治疗的一种危及生命的并发症：临床表型及治疗反应——文献综述
J Clin Med. 2024 Mar 11;13(6):1598. doi: 10.3390/jcm13061598.
2
Thrombotic Microangiopathy after a 15-year Treatment with Interferon Beta-1b in a Patient with Multiple Sclerosis: A Case Report and Review of Literature.一名多发性硬化症患者接受15年β-1b干扰素治疗后发生血栓性微血管病：病例报告及文献复习
Intern Med. 2024 Apr 15;63(8):1113-1117. doi: 10.2169/internalmedicine.1846-23. Epub 2023 Sep 1.
3
Renal diseases secondary to interferon-β treatment: a multicentre clinico-pathological study and systematic literature review.
继发于干扰素-β治疗的肾脏疾病：一项多中心临床病理研究及系统文献综述
Clin Kidney J. 2021 Jul 6;14(12):2563-2572. doi: 10.1093/ckj/sfab114. eCollection 2021 Dec.
4
A case report of late-onset atypical Hemolytic Uremic Syndrome during interferon beta in multiple sclerosis: Open issues in literature review.多发性硬化症患者使用干扰素-β后迟发性非典型溶血尿毒综合征 1 例报告：文献复习中的开放性问题。
Brain Behav. 2021 Jan;11(1):e01930. doi: 10.1002/brb3.1930. Epub 2020 Dec 16.
5
Induction or aggravation of other immune-mediated disorders by disease-modifying therapy in treatment of multiple sclerosis.在治疗多发性硬化症时，疾病修饰疗法引发或加重其他免疫介导疾病。
Iran J Neurol. 2018 Jul 6;17(3):129-136.
6
Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab.干扰素β诱导的多发性硬化症患者血栓性微血管病：3例接受依库珠单抗治疗的病例
Clin Kidney J. 2017 Oct;10(5):625-631. doi: 10.1093/ckj/sfw143. Epub 2017 Feb 16.